The Operating System
for Biologicals.
Next-Generation Nutrition
A Knowledge Intensive Company developing clinically potent crops inside advanced vertical-farming systems — creating high-value ingredients for nutraceutical and pharma-adjacent products using Bioencapsulated Peptide Synthesis
What We Do
We combine precision agriculture, clinical nutrition and bioactive optimisation to create high-value ingredients for sports nutrition, pharma and GLP-1 receptor agonists (eg. similar to Ozempic, Mounjaro etc).
We are raising £500,000 (EIS) to further scale R&D, secure IP, certify products and manufacture BioCube units.
SEIS, EIS Round 1 and EIS Round 2 are now closed. EIS Round 3 investors have a limited opportunity to enter at 7.50p per share — against a current valuation of 12.65p per share.
Why the Industry Needs Us
Consumers demand precision nutrition, yet most functional ingredients fall short of clinical standards. Industry demand for high-potency, contaminant-free, traceable ingredients is at an all-time high.
Inconsistent Potency
Variable bioactive concentrations compromise efficacy in functional ingredients.
Contamination Risk
Pesticides and heavy metals present serious safety concerns for consumers.
Supply Chain Degradation
Long transport routes reduce nutritional value before products reach consumers.
Climate Vulnerability
Traditional farming is exposed to weather volatility and climate change.
